Evidence map›Paper›PMID 33608456›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

The Zinc Finger Protein Zbtb18 Represses Expression of Class I Phosphatidylinositol 3-Kinase Subunits and Inhibits Plasma Cell Differentiation.

Bin Xie, Tariq E Khoyratty, Enas Abu-Shah, Pablo F Cespedes, Andrew J MacLean, Gabriela Pirgova, Zhiyuan Hu, Ahmed A Ahmed, Michael L Dustin, Irina A Udalova and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Bin XieKennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, United Kingdom; and.
Tariq E KhoyrattyKennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, United Kingdom; and.ORCID 0000-0001-5911-0026
Enas Abu-ShahKennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, United Kingdom; and.ORCID 0000-0001-5033-8171
Pablo F CespedesKennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, United Kingdom; and.ORCID 0000-0002-1641-4107
Andrew J MacLeanKennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, United Kingdom; and.
Gabriela PirgovaKennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, United Kingdom; and.
Zhiyuan HuOvarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford OX3 9DS, United Kingdom.ORCID 0000-0002-1688-6032
Ahmed A AhmedOvarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford OX3 9DS, United Kingdom.
Michael L DustinKennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, United Kingdom; and.ORCID 0000-0003-4983-6389
Irina A UdalovaKennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, United Kingdom; and.
Tal I ArnonKennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, United Kingdom; and tal.arnon@kennedy.ox.ac.uk.ORCID 0000-0003-4629-5820
University of Oxford · GB

Funding

Wellcome Trust 106245
6 · The paper itself

Abstract

The PI3K pathway plays a key role in B cell activation and is important for the differentiation of Ab producing plasma cells (PCs). Although much is known about the molecular mechanisms that modulate PI3K signaling in B cells, the transcriptional regulation of PI3K expression is poorly understood. In this study, we identify the zinc finger protein Zbtb18 as a transcriptional repressor that directly binds enhancer/promoter regions of genes encoding class I PI3K regulatory subunits, subsequently limiting their expression, dampening PI3K signaling and suppressing PC responses. Following activation, dividing B cells progressively downregulated Zbtb18, allowing gradual amplification of PI3K signals and enhanced development of PCs. Human Zbtb18 displayed similar expression patterns and function in human B cells, acting to inhibit development of PCs. Furthermore, a number of Zbtb18 mutants identified in cancer patients showed loss of suppressor activity, which was also accompanied by impaired regulation of PI3K genes. Taken together, our study identifies Zbtb18 as a repressor of PC differentiation and reveals its previously unappreciated function as a transcription modulator of the PI3K signaling pathway.

Indexed as

AnimalsB-LymphocytesCell DifferentiationGene Expression RegulationHumansImmunity, HumoralLymphocyte ActivationMiceMice, Inbred C57BLMutationNeoplasmsPhosphatidylinositol 3-KinasesPlasma CellsRepressor ProteinsSignal TransductionPhosphatidylinositol 3-KinasesRepressor ProteinsZBTB18 protein, human

Identifiers

PMID33608456
PMCPMC7980533
OpenAlexW3131832908

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.